Abstract
Endothelial dysfunction is associated with endothelial cell activation, i.e., up-regulation of surface cell adhesion molecules and the release of proinflammatory cytokines. 20-Hydroxyeicosatetraenoic acid (HETE), a major vasoactive eicosanoid in the microcirculation, has been implicated in the regulation of endothelial cell function through its angiogenic and pro-oxidative properties. We examined the effects of 20-HETE on endothelial cell activation in vitro. Cells transduced with adenovirus containing either CYP4A1 or CYP4A2 produced higher levels of 20-HETE, and they demonstrated increased expression levels of the adhesion molecule intercellular adhesion molecule (ICAM) (4–7-fold) and the oxidative stress marker 3-nitrotyrosine (2–3-fold) compared with cells transduced with control adenovirus. Treatment of cells with 20-HETE markedly increased levels of prostaglandin (PG) E2 and 8-epi-isoprostane PGF2α, commonly used markers of activation and oxidative stress, and most prominently, interleukin-8, a potent neutrophil chemotactic factor whose overproduction by the endothelium is a key feature of vascular injury. 20-HETE at nanomolar concentrations increased inhibitor of nuclear factor-κB phosphorylation by 2 to 5-fold within 5 min, which was followed with increased nuclear translocation of nuclear factor-κB (NF-κB). Likewise, 20-HETE activated the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) pathway by stimulating phosphorylation of ERK1/2. Inhibition of NF-κB activation and inhibition of ERK1/2 phosphorylation inhibited 20-HETE-induced ICAM expression. It seems that 20-HETE triggers NF-κB and MAPK/ERK activation and that both signaling pathways participate in the cellular mechanisms by which 20-HETE activates vascular endothelial cells.
Footnotes
-
This study was supported by National Institutes of Health Grants HL34300 and EY06513 (to M.L.-S.) and DK38226 (to J.R.F.) and by the Robert A. Welch Foundation (to J.R.F.) and American Heart Association predoctoral fellowship 0715781T (to J.C.).
-
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
-
doi:10.1124/jpet.107.130336.
-
ABBREVIATIONS: HETE, hydroxyeicosatetraenoic acid; P450, cytochrome P450; eNOS, endothelial nitric-oxide synthase; ICAM, intracellular adhesion molecule; IL, interleukin; NF-κB, nuclear factor-κB; MAPK, mitogen-activated protein kinase; ERK, extracellular signal-regulated kinase; IκB, inhibitor of nuclear factor-κB; MAP, mitogen-activated protein; PDTC, pyrrolidinedithiocarbamate; PD98059, 2′-amino-3′-methoxyflavone; U0126, 1,4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene; PBS, phosphate-buffered saline; 8-isoP, 8-epi-isoprostane prostaglandin F2α; PG, prostaglandin; Adv, adenovirus; GFP, green fluorescent protein; ROS, reactive oxygen species; SN50, H2N-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Val-Gln-Arg-Lys-Arg-Gln-Lys-Leu-Met-Pro-OH.
- Received August 31, 2007.
- Accepted October 17, 2007.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|